Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 5

Genotype distribution in Hepatitis C patients admitted to Erzincan Mengücek Gazi Training and Research Hospital

Pages
1369–1373
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

HCV G1 (1.3%) was detected in 1, HCV G4 (1.3%) in 1 patient.Conclusion: The dominant genotype in Hepatitis C patients who applied to Mengücek Gazi Training and Research Hospital wasdetermined as “HCV Genotype 1b”.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: We aimed to determine the genotype distribution in Hepatitis C patients who Parasitology applied to Erzincan Binali YildirimUniversity, Mengücek Gazi Training and Research Hospital.
📊
Key Findings & Data:Hepatitis C virus, the only member of the genus Hepacivirus of Flaviviridaefamily, is responsible for 25%-40% of all liver diseases.
💡
Conclusion & Impact:HCV G1 (1.3%) was detected in 1, HCV G4 (1.3%) in 1 patient.Conclusion: The dominant genotype in Hepatitis C patients who applied to Mengücek Gazi Training and Research Hospital wasdetermined as “HCV Genotype 1b”.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: We aimed to determine the genotype distribution in Hepatitis C patients who Parasitology applied to Erzincan Binali YildirimUniversity, Mengücek Gazi Training and Research Hospital. Hepatitis C virus, the only member of the genus Hepacivirus of Flaviviridaefamily, is responsible for 25%-40% of all liver diseases. Hepatitis C virus causes acute hepatitis C and chronic hepatitis C infections.Chronic hepatitis C infection causes cirrhosis, liver failure, hepatocellular cancerand liver diseases in terminal periods.Material and Methods: A total of 77 patients, 41 male and 36 female, who were admitted to Erzincan Binali Yıldırım University,Mengücek Gazi Training and Research Hospital in the period of January 2013-June 2019, were included in our study. RT-PCR andDNA sequencing for the 5’UTR region of the HCV genome for HCV genotyping was performed using the ABI Prism 3130 × 1 DNASequencer device.Results: Sex of a total of 77 patients included in the study; 41 of them are men (53.2%) and 36 are women (46.8%). Average age of thepatients; It was 59.9 ± 16.6 (minimum 20 and maximum 94). HCV G1b (80.5%) in 62 patients, HCV G1a (7.8%) in 6, HCV G3a (3.9%)in 3, HCV G3 (2.6%) in 2 and HCV G2 (2.6%) was found in 2 patients. HCV G1 (1.3%) was detected in 1, HCV G4 (1.3%) in 1 patient.Conclusion: The dominant genotype in Hepatitis C patients who applied to Mengücek Gazi Training and Research Hospital wasdetermined as “HCV Genotype 1b”.

🔖

Cite This Article

ARSLAN, Y. K., KARAKEÇİLİ, F., YILMAZ, A., KARA, M., DABANLIOĞLU, B. (2022). Genotype distribution in Hepatitis C patients admitted to Erzincan Mengücek Gazi Training and Research Hospital. Annals of Medical Research, Cilt: 27 - Sayı: 5, 1369–1373. https://ajindex.com/articles/447050

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Choo Q, Kuo G, Weiner A, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62
  2. World Health Organization.Monitoring and evaluation for viral hepatitis B and C: recommended indicators and framework. (Erişimtarihi:4.2016)
  3. LiuCH, Liang CC, Liu CJ, et al. Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C. Clin Infect Dis 2010;51:541-9
  4. International Committee on Taxonomy of HCV genotypes and subtypes.https://talk.ictvonline. org/ictv_wikis/flaviviridae/w/sg_flavi/634/table1---confirmed-hcv-genotypes-subtypes-may- (Erişimtarihi: 8.5.2019)
  5. World Health Organization. Hepatitis C.https://www. who.int/news-room/fact-sheets/detail/hepatitisc(Erişimtarihi: 9.7.2019)
  6. BuschMP, Glynn SA, Stramer, SL, et al. A new strategy for estimating risks of Transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-64
  7. Shalmani HM, Ranjbar M, Alizadeh, AHM. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronicdisease. J Liver 2013;3:889-2167 8. Alter MJ.Prevention of spread of hepatitis C. Hepatology 2002;36:93-8
  8. Shepard CW, Finelli L, Alter MJ.Global epidemiology of hepatitis Cvirus infection. Lancet 2005;5:558-67
  9. Yildirim B, Tahan V, Ozaras R. et al. Hepatitis C virus risk factors in the Turkish community. Dig Dis Sci 2005;50:2352-5. Ann Med Res 2020;27(4):1369-73 11. Caruntu FA, Benea L. Acute hepatitis C virus infection: Diagno¬sis, pathogenesis, treatment.Gastrointestin Liver Dis 2006;15:249-56
  10. World Health Organization. Guidelines for the Screening, Careand Treatment of Persons with Hepatitis C Infection.https://apps.who.int/iris/bitstream/ handle/10665/205035/9789241549615_eng. F7E027BBB8?sequence=1(Erişimtarihi:27.4.2016)
  11. Altuglu I, Soyler I, Ozacar T, et al. Distribution of hepatitis C virus genotypes inpatients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis 2008;12:239-44
  12. Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C vi¬rus infection. J Hepatol 2014;61:45-57
  13. Gurbuz Y, Tutuncu EE, Tulek NE, et al. Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study. Balkan Med J 2016;33:18-26
  14. Altuğlu I, Sertoz R, Aksoy A, et al.Possible transmission risks